Karen M. Clements, ScD

home / authors / karen-m-clements-scd

Articles

July 13th 2022

Cost-Benefit Analysis of Sacubitril/Valsartan in a Medicaid Population

Alan Gabot, PharmD Pavel Lavitas, PharmD, BCPS Rachel Bacon, PharmD, MPH Thomas C. Pomfret, PharmD, MPH, BCPS Mckenzie Taylor, PharmD, MS Andrew Coelho, PharmD Bonnie C. Greenwood, PharmD, BCPS Caroline J. Alper, MD Karen M. Clements, ScD Kimberly Lenz, PharmD, MBA

The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan.

November 16th 2021

Evaluating Proactive Outreach for Prior Authorization Recertifications in Medicaid Patients

Soumya Vishwanath, PharmD Stephanie N. Tran, PharmD, BCPS Thomas C. Pomfret, PharmD, MPH, BCPS Kaelyn C. Boss, PharmD Mark Tesell, PharmD, BCPS Mylissa Price, MPH, RPh Caroline J. Alper, MD Lorean Muchnik, RPh Karen M. Clements, ScD Kimberly Lenz, PharmD

Implementing a proactive provider outreach program resulted in significantly more prior authorization recertifications and a reduction in time to submission.